Juguet, W.; Fard, D.; Faivre, L.; Koutsoukis, A.; Deguillard, C.; Mongardon, N.; Mekontso-Dessap, A.; Huguet, R.; Lim, P.
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine. J. Clin. Med. 2020, 9, 3605.
https://doi.org/10.3390/jcm9113605
AMA Style
Juguet W, Fard D, Faivre L, Koutsoukis A, Deguillard C, Mongardon N, Mekontso-Dessap A, Huguet R, Lim P.
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine. Journal of Clinical Medicine. 2020; 9(11):3605.
https://doi.org/10.3390/jcm9113605
Chicago/Turabian Style
Juguet, William, Damien Fard, Laureline Faivre, Athanasios Koutsoukis, Camille Deguillard, Nicolas Mongardon, Armand Mekontso-Dessap, Raphaelle Huguet, and Pascal Lim.
2020. "Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine" Journal of Clinical Medicine 9, no. 11: 3605.
https://doi.org/10.3390/jcm9113605
APA Style
Juguet, W., Fard, D., Faivre, L., Koutsoukis, A., Deguillard, C., Mongardon, N., Mekontso-Dessap, A., Huguet, R., & Lim, P.
(2020). Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine. Journal of Clinical Medicine, 9(11), 3605.
https://doi.org/10.3390/jcm9113605
